A reference interval describes a comparison range used by a laboratory. A treatment target describes an aim chosen in a care plan. They can appear near each other in health information, but they are not the same kind of statement.
Three meanings that are easy to mix up
Reference interval: a range associated with a defined reference group and test method.
Diagnostic criterion: a result or combination of findings used within a clinical process to identify a condition.
Treatment goal: a result a clinician and patient may aim for while managing an established condition.
For example, the use of A1c in diagnosing diabetes is a different question from choosing an A1c goal for someone already being treated. Confirmation, health history, and individual circumstances affect how these decisions are made.
Why copying a range can mislead
An internet chart may use another method, unit, age group, or purpose. Copying its boundaries beside your result can create a false flag or remove a meaningful one. The laboratory's own interval belongs with the measurement; the clinician's explanation belongs with the treatment plan.
Even then, being inside an interval does not guarantee that every symptom has been explained. Being outside one does not automatically establish a disease. Results are interpreted with the reason for testing and other information.
Label your notes accurately
If you keep a personal record, use separate columns for “laboratory interval” and “goal discussed with clinician.” Include the date of that discussion. Avoid renaming either column “perfect result.”
When a portal flag seems to conflict with your care plan, ask the clinician to explain the difference. Do not change a medicine to force a value into a generic range. The distinction is useful precisely because it prevents a reporting convention from becoming an unsupervised treatment instruction.
Sources
- MedlinePlus: Understanding laboratory results
Reference intervals, clinical context, false results, and follow-up limitations.
- NIDDK: The A1c test and diabetes
A1c and glucose can disagree; red blood cell factors and clinical purpose affect use.